Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

Clinical trial NCT05411081 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05411081
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Papillary Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v8

Start date: 2023-03-24
Primary completion: 2027-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.